5/9
04:35 pm
ltrn
Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
High
Report
Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
5/9
04:02 pm
ltrn
Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights
Medium
Report
Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights
5/6
06:56 am
ltrn
Lantern Pharma and Oregon partner to develop cancer treatment [Yahoo! Finance]
High
Report
Lantern Pharma and Oregon partner to develop cancer treatment [Yahoo! Finance]
5/6
03:09 am
ltrn
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism [Yahoo! Finance]
High
Report
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism [Yahoo! Finance]
5/6
03:00 am
ltrn
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
High
Report
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
5/2
07:44 am
ltrn
Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET [Yahoo! Finance]
Medium
Report
Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET [Yahoo! Finance]
5/2
07:30 am
ltrn
Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET
Medium
Report
Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET
4/25
08:01 am
ltrn
Lantern Pharma Inc. (NASDAQ: LTRN) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
Lantern Pharma Inc. (NASDAQ: LTRN) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
4/24
08:07 am
ltrn
Lantern Pharma Launches "Webinar Wednesdays" Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development [Yahoo! Finance]
Medium
Report
Lantern Pharma Launches "Webinar Wednesdays" Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development [Yahoo! Finance]
4/24
08:00 am
ltrn
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Medium
Report
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
4/22
08:24 am
ltrn
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan [Yahoo! Finance]
Medium
Report
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan [Yahoo! Finance]
4/22
08:12 am
ltrn
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
Medium
Report
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
4/10
08:45 am
ltrn
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
Low
Report
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
4/10
08:45 am
ltrn
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
Low
Report
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
3/19
09:20 am
ltrn
Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/18
04:12 pm
ltrn
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights [Yahoo! Finance]
High
Report
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights [Yahoo! Finance]
3/18
04:02 pm
ltrn
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
High
Report
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
3/15
08:00 am
ltrn
Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
High
Report
Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
3/11
07:41 am
ltrn
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET [Yahoo! Finance]
High
Report
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET [Yahoo! Finance]
3/11
07:30 am
ltrn
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
High
Report
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
3/5
08:10 am
ltrn
Lantern To Participate in H.C Wainwright & Co.'s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference [Yahoo! Finance]
Low
Report
Lantern To Participate in H.C Wainwright & Co.'s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference [Yahoo! Finance]
3/5
08:01 am
ltrn
Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
Low
Report
Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
3/4
08:09 am
ltrn
Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines [Yahoo! Finance]
Medium
Report
Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines [Yahoo! Finance]
3/4
08:01 am
ltrn
Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines
Medium
Report
Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines